Search results
Results from the WOW.Com Content Network
Post-mastectomy pain syndrome is a chronic neuropathic pain that usually manifests as continuous pain in the arm, axilla, chest wall, and breast region. [3] Pain is most likely to start after surgery, [3] although adjuvant therapy, such as chemotherapy or radiation therapy, may sometimes cause new symptoms to appear. [4]
After Katie Couric was diagnosed with breast cancer, she chose a lumpectomy, not a mastectomy, as her treatment. What to know about breast-conserving surgery.
Lumpectomy (sometimes known as a tylectomy, partial mastectomy, breast segmental resection or breast wide local excision) is a surgical removal of a discrete portion or "lump" of breast tissue, usually in the treatment of a malignant tumor or breast cancer. [1]
Postoperative pain is common following breast surgery. The incidence of poorly controlled acute postoperative pain following breast cancer surgery ranges between 14.0% to 54.1%. [11] Regional anaesthesia is superior compared to general anaesthesia for the prevention of persistent postoperative pain three to 12 months after breast cancer surgery ...
Sep. 2—MITCHELL, S.D. — It was this past May when Sister Marita Pfau first noticed an unusual indentation on her breast during a self-exam. "I happen to notice that in the mirror, whether I ...
Mastectomy is the medical term for the surgical removal of one or both breasts, partially or completely.A mastectomy is usually carried out to treat breast cancer. [1] [2] In some cases, women believed to be at high risk of breast cancer choose to have the operation as a preventive measure. [1]
Staging breast cancer is the initial step to help physicians determine the most appropriate course of treatment. As of 2016, guidelines incorporated biologic factors, such as tumor grade, cellular proliferation rate, estrogen and progesterone receptor expression, human epidermal growth factor 2 (HER2) expression, and gene expression profiling into the staging system.
Breast-conserving surgery may also be used in cases of biopsy-proven invasive breast cancer or biopsy-proven ductal carcinoma in situ. In the assessment of the tumor, the surgeon should assess the ability to resect the tumor with clear margins while providing a cosmetic result that is acceptable to the patient.